Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

Share Price is delayed by 15 minutes
Get Live Data
20.50    0.50 (2.50%)
Bid:
20.00
Ask:
21.00
Spread: 1.00 (5.00%)
Market Cap: £14.99m
ALT Live PriceLast checked at - London Stock Exchange

Intraday Altitude Group Share Chart

Directorate Change

6 Mar 2025 07:00

RNS Number : 5040Z
Altitude Group PLC
06 March 2025
 

6 March 2025

 

Altitude Group plc

("Altitude", the "Group" or the "Company")

 

Appointment of Non-Executive Chairman

and

Directorate Change

 

 

Altitude Group Plc (AIM: ALT), the leading end-to-end solutions provider for branded merchandise, is pleased to announce that Alexander Brennan has been appointed as independent Non-Executive Chairman of the Company with immediate effect.

 

In consideration of increasing commitments and opportunities from other directorships, David Smith, having completed his term as the Altitude Chairman, has decided to step down from his role as Chairman and Board Director, with effect from Alexander's appointment as the new Chairman. The Board understand the reasons for David's decision and wish to thank him for his valuable contribution to the Group during his term and wish him well in his future endeavours.

 

As the current Interim Chairman of Big Technologies plc, Alexander brings relevant experience chairing a plc board. In addition, Alexander has two decades' experience of delivering growth for businesses in the UK and internationally, both as principal and as an advisor, with particular experience in the technology sector. He was previously an Executive Director at Symphony Environmental Technologies plc. Alexander founded Brennan & Partners in 2016, a UK-headquartered consultancy, providing business development advisory services for UK and international clients. Prior to this, he worked at De La Rue Plc for five years, focusing on B2G and B2B sales across Europe and the Americas. Alexander began his career at Slaughter and May where he practised as a corporate and M&A lawyer for six years.

 

Nichole Stella, CEO of Altitude, commented:

 

"On behalf of the Company, I would like to express my gratitude to David for his leadership as Chairman. His time at the helm of Altitude has been a period of significant success and growth. We are excited to welcome Alexander to the Board and look forward to collaborating with him as our new Chairman. Alexander's expertise in technology and experience with expanding international businesses will be invaluable as we enter the next phase of scalability and growth."

 

Alexander Brennan, Non-Executive Chairman of Altitude, commented:

 

"I am delighted to be stepping into the role of Chairman of Altitude Group at an exciting and pivotal time for the company, particularly during this period of scalable expansion which presents significant opportunities for the Company. I look forward to working closely with the Board to ensure we continue to drive growth and maximise value for our shareholders"

 

In accordance with Schedule 2(g) of the AIM Rules for Companies, Alexander Manuel Philip Martin Brennan (aged 44) holds, or has held in the past five years, the following directorships and partnerships:

 

Current Directorships

Directorships held in last 5 years

Brennan & Partners Limited

Symphony Environmental Technologies PLC

The Hispanic and Luso Brazilian Council (Trustee)

 

Proyectos Onddi, S.A.

Big Technologies PLC

 

Alexander holds no shares in the Company.

 

There is no further information on Alexander Brennan required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

 

For enquiries, please contact:

Altitude Group plc 

Nichole Stella, Chief Executive Officer 

Graham Feltham, Chief Financial Officer 

 

Via Zeus 

Zeus (Nominated Adviser & Broker) 

Dan Bate / James Edis (Investment Banking) 

Dominic King (Corporate Broking) 

Tel: 0203 829 5000 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABXGDXXXGDGUU
Date   Source Headline
8th Jun 20267:00 amRNSDirector/PDMR Shareholding
1st Jun 20268:31 amRNSExercise & Grant of Options and TVR
17th Apr 20267:00 amRNSBoard Role Change
14th Apr 20263:25 pmRNSDirector/PDMR Dealing
9th Apr 202612:00 pmRNSDirector/PDMR Dealing
31st Mar 20267:00 amRNSTrading Update
5th Mar 20263:39 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSAppointment of Independent Non-Executive Director
10th Feb 202612:32 pmRNS-RAppointment of Chief Commercial Officer
4th Feb 20267:00 amRNSAppointment of Nominated Adviser and Sole Broker
19th Jan 20261:33 pmRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
1st Dec 20259:01 amRNSPDMR Dealing
28th Nov 20257:00 amRNSChange of Registered Office
27th Nov 20254:57 pmRNSCorrection: Exercise & Grant of Options and TVR
27th Nov 20257:30 amRNSExercise & Grant of Options, PDMR Dealings and TVR
27th Nov 20257:00 amRNSInterim Results
11th Nov 20257:00 amRNSTrading Update, Board Change and Notice of Results
30th Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20257:00 amRNSResult of AGM
12th Sep 20257:00 amRNSDirector/PDMR Dealing
11th Sep 20257:00 amRNSDirector/PDMR Dealing
10th Sep 20257:00 amRNSDirector/PDMR Dealing
8th Sep 20257:00 amRNSDirector/PDMR Dealing
5th Sep 20257:00 amRNSDirector/PDMR Dealing
15th Aug 20254:20 pmRNSChange of Venue for the 2025 AGM
7th Aug 20257:00 amRNSAudited Annual Results and Notice of AGM
30th Jul 20257:00 amRNSNotice of Results
15th Jul 20257:00 amRNSBoard Changes and Trading Update
23rd Jun 20257:00 amRNSAppointment of CFO
17th Jun 20257:00 amRNSBoard Change and Trading Update
15th May 20257:00 amRNSGrant of Options and PDMR Dealings
9th May 20255:50 pmRNSDirector/PDMR Dealing
9th Apr 20257:00 amRNSExercise of Options, Director Dealings and TVR
1st Apr 20257:00 amRNSDirector/PDMR Dealing
31st Mar 20257:00 amRNSTrading Update and New University Contract Awards
28th Mar 20257:00 amRNSChange of Registered Office
11th Mar 20257:00 amRNSDirector/PDMR Dealings
6th Mar 20257:00 amRNSDirectorate Change
3rd Dec 20247:00 amRNSInterim Results
15th Nov 20247:00 amRNSTrading Update and Notice of Results
8th Oct 20244:04 pmRNSHolding(s) in Company
23rd Sep 20244:47 pmRNSResult of AGM
6th Sep 202412:30 pmRNSPosting of Annual Report and Notice of AGM
30th Jul 20247:00 amRNSAudited Annual Results and Notice of AGM
23rd Jul 20247:00 amRNSFull Year Trading Update
3rd Jun 20249:28 amRNSExercise of Options, Director Dealings and TVR
20th May 20247:00 amRNSGrant of Options and PDMR Dealings
1st May 20247:00 amRNSPre-Close Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.